Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares gapped down before the market opened on Thursday . The stock had previously closed at $338.55, but opened at $281.55. Bio-Rad Laboratories shares last traded at $279.91, with a volume of 400 shares trading hands.

Bio-Rad Laboratories Price Performance

The stock has a market cap of $7.98 billion, a P/E ratio of -13.03 and a beta of 0.70. The company has a debt-to-equity ratio of 0.14, a quick ratio of 4.34 and a current ratio of 5.83. The firm has a 50-day moving average price of $321.43 and a 200-day moving average price of $315.75.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings results on Thursday, February 15th. The company reported $3.10 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The company had revenue of $681.18 million during the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.